Head of US Therapeutic Dermatology Market Development Strategy

Galderma is the emerging pure-play dermatology category leader present in approximately 90 countries. We deliver an innovative science-based portfolio of premium flagship brands and services that span the full spectrum of the fast-growing dermatology market through Injectable Aesthetics Dermatological Skincare and Therapeutic Dermatology. Since our foundation in 1981 we have dedicated our focus and passion to the human bodys largest organ - the skin - meeting individual consumer and patient needs with superior outcomes in partnership with healthcare professionals. Because we understand that the skin we are in shapes our lives we are advancing dermatology for every skin story.

We look for people who focus on getting results embrace learning and bring a positive energy. They must combine initiative with a sense of teamwork and collaboration. Above all they must be passionate about doing something meaningful for consumers patients and the healthcare professionals we serve every day. We aim to empower each employee and promote their personal growth while ensuring business needs are met now and into the future. Across our company we embrace diversity and respect the dignity privacy and personal rights of every employee.

At Galderma we actively give our teams reasons to believe in our bold ambition to become the leading dermatology company in the world. With us you have the ultimate opportunity to gain new and challenging work experiences and create an unparalleled direct impact.

Job Summary

The Head of U.S. Pipeline Commercial Development will report directly to the U.S. Head of Therapeutic Dermatology and play a pivotal role in unlocking the full commercial potential of Nemluvio in the U.S. market while shaping the commercial strategy for future pipeline assets. This leader will serve as the single point of accountability for integrating U.S. commercial priorities with global clinical development finance medical affairs access and regulatory teams to ensure U.S. market needs are embedded in lifecycle and evidence generation plans.

This role is designed for a strategic enterprise-minded executive who can bridge early-stage development with late-stage commercial readinessmaximizing long-range value creation for the franchise.

Key Responsibilities

Strategic Leadership & Cross-Functional Integration

Lead the U.S. Long-Range Planning (LRP) strategy team across commercial medical clinical regulatory market access and insights functions.

Serve as the U.S. representative on the global core asset team influencing lifecycle planning and global development strategy.

Shape and evolve the Target Product Profile (TPP) indication sequencing and label strategy to ensure alignment with U.S. market access and commercial needs.

Translate complex clinical and market insights into clear strategic and financial implications for U.S. business planning.

Ensure seamless collaboration with U.S. and Global Finance to drive accurate peak sales modeling scenario planning and trade-off frameworks aligned with portfolio priorities.

Commercial & Clinical Strategy Integration

Partner closely with global clinical and regulatory leads to influence study designs endpoints and evidence generation plans that optimize U.S. launch readiness and payer acceptance.

Anticipate and shape data needs for regulatory submissions pricing negotiations and payer value propositions.

Champion the U.S. voice in global decision-making forums ensuring data strategies timelines and lifecycle investments reflect commercial realities and opportunities.

Leadership & Organizational Impact

Lead and develop a high-performing cross-functional team focused on pipeline and portfolio value maximization.

Foster a culture of strategic agility scientific rigor and commercial excellence.

Represent the U.S. commercial organization in senior governance forums providing fact-based recommendations that drive asset and portfolio prioritization.

Partner with brand leadership to ensure continuity between early development and launch execution phases.

Proposed Skills & Qualifications

Advanced degree (MBA PharmD MD or equivalent preferred).

Minimum 15 years of experience in biopharma with significant exposure to U.S. commercial strategy global development and lifecycle management.

Proven track record in early commercial development and/or pipeline strategy roles ideally within specialty or dermatology therapeutic areas.

Demonstrated success influencing global development teams and shaping clinical programs to align with commercial and payer needs.

Experience leading cross-functional or matrixed teams with direct accountability for financial outcomes.